CN115844934A - A method for treating sexual impotence and prostatitis - Google Patents
A method for treating sexual impotence and prostatitis Download PDFInfo
- Publication number
- CN115844934A CN115844934A CN202211424784.1A CN202211424784A CN115844934A CN 115844934 A CN115844934 A CN 115844934A CN 202211424784 A CN202211424784 A CN 202211424784A CN 115844934 A CN115844934 A CN 115844934A
- Authority
- CN
- China
- Prior art keywords
- patient
- prostatitis
- prostate
- mass
- granules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000001881 impotence Diseases 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 20
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 19
- 208000010228 Erectile Dysfunction Diseases 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 30
- 210000002307 prostate Anatomy 0.000 claims abstract description 16
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 claims abstract description 14
- 229960003376 levofloxacin Drugs 0.000 claims abstract description 14
- 239000008187 granular material Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 210000002784 stomach Anatomy 0.000 claims abstract description 7
- 230000014759 maintenance of location Effects 0.000 claims abstract description 5
- 239000011259 mixed solution Substances 0.000 claims abstract description 4
- 238000010298 pulverizing process Methods 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 230000000694 effects Effects 0.000 abstract description 8
- 201000006549 dyspepsia Diseases 0.000 abstract description 6
- 239000002245 particle Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229940094720 viagra Drugs 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000331432 Cynanchum wilfordii Species 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 229960000711 alprostadil Drugs 0.000 description 1
- 229960004046 apomorphine Drugs 0.000 description 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229960002802 bromocriptine Drugs 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 1
- 229960001999 phentolamine Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229960000317 yohimbine Drugs 0.000 description 1
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 1
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a method for treating impotence and prostatitis, which comprises the following steps: the method comprises the following steps: pulverizing levofloxacin tablets and the radix cynanchi wilfordii food retention removing granules, mixing, adding water, stirring and dissolving to obtain a mixed solution; step two: and (2) enabling the mixed liquid in the first step to flow into the prostate of the patient by using an auxiliary pipe, enabling the patient to wait for 30min while lying on the stomach, enabling the mass of the levofloxacin tablets in the first step to be 0.2-0.4g, the mass of the particles for removing food retention in the radix cynanchi wilfordii to be 4-8g, and the mass of water to be 10-15g, and enabling the patient to need to lie on the stomach to take medicine when taking medicine to the prostate of the patient in the second step. The levofloxacin tablets and the radix cynanchi wilfordii dyspepsia granules are mixed and dissolved and then flow into the prostate of a patient, the mixed liquid medicine enters the prostate by adopting a medicine feeding way on the front, and the effect on impotence and prostatitis is better by mixing the levofloxacin tablets and the radix cynanchi wilfordii dyspepsia granules.
Description
Technical Field
The invention relates to the technical field of impotence treatment, in particular to a method for treating impotence and prostatitis.
Background
Impotence and prostatitis are common diseases in the andrology. The common methods for treating impotence in western medicine at present are hormone therapy, drug therapy and surgical therapy. The oral drugs can be divided into central drugs such as apomorphine, yohimbine, bromocriptine, etc., and peripheral drugs such as Wanyike and phentolamine, etc. Another non-invasive treatment is treatment via the cutaneous and living urethral mucosal route: the ED external medicine applied to the penis skin comprises nitroglycerin patch or emulsion, prostate E1 emulsion, minoxidil emulsion and the like; examples of drugs for treating ED via the urethral route include alprostadil and the like. At present, oral citric acid shake polyphenol (Viagra) is a medicament for treating impotence with quick response and good curative effect, and is popular with patients. However, the following problems are common to western medicine therapy: (1) Although western medicines have the advantage of quick response, the western medicines are temporary medicines, usually take effect temporarily, and have the phenomenon of more serious impotence after stopping taking the medicines; (2) The used medicines have obvious adverse reactions, wherein the medicines for regulating the central nervous system are easy to generate dependence, for example, the obvious adverse reactions after the medicines of citric acid shake polyphenol (Viagra) which is generally popular in recent years are taken are reported. The traditional Chinese medicine has long history of impotence and accumulates abundant experience. Based on the holistic concept, TCM advocates warming and recuperating kidney yang and filling up essence and blood as the main therapeutic principle of impotence. A great deal of clinical experience for treating the diseases is accumulated, the traditional Chinese medicine can treat both symptoms and root causes, some of the traditional Chinese medicine have good treatment effect in some aspect, and most of the traditional Chinese medicine are still in a state of traditional Chinese medicine preparation, so that the traditional Chinese medicine is not beneficial to direct taking.
Prostatitis is one of the common diseases of middle-aged and young men and can be divided into acute and chronic diseases. Acute prostatitis is an acute inflammation of the prostate gland and ducts caused by bacteria or their toxins; chronic prostatitis can be secondary to acute prostatitis or chronic posterior urethritis, and can also be secondary to infection at other parts of the body.
But impotence and prostatitis have poor curative effect and large side effect at present, which is inconvenient for patients to use.
Disclosure of Invention
The present invention aims to provide a method for treating impotence and prostatitis, which solves the problems in the background art.
In order to solve the technical problems, the invention provides the following technical scheme: a method for treating impotence and prostatitis comprising the steps of:
the method comprises the following steps: pulverizing levofloxacin tablets and the radix cynanchi wilfordii food retention removing granules, mixing, adding water, stirring and dissolving to obtain a mixed solution;
step two: and (4) using the auxiliary pipe to flow the mixed liquid in the step (I) into the prostate of the patient, and the patient lies on the stomach to wait for 20-40min.
In a preferred embodiment, in the first step, the mass of the levofloxacin tablets is 0.2-0.4g, the mass of the Daoshanxiaoji granules is 4-8g, and the mass of the water is 10-15g.
In a preferred embodiment, the administration of the drug to the prostate of the patient in step two requires that the patient be on his or her stomach.
Compared with the prior art, the invention has the following beneficial effects:
the levofloxacin tablets and the radix cynanchi wilfordii dyspepsia granules are mixed and dissolved and then flow into the prostate of a patient, the mixed liquid medicine enters the prostate by adopting a medicine feeding way on the front, and the effect on impotence and prostatitis is better by mixing the levofloxacin tablets and the radix cynanchi wilfordii dyspepsia granules.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below by referring to specific examples, and it is obvious that the described examples are only a part of the embodiments of the present invention, but not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a method for treating impotence and prostatitis, which comprises the following steps:
the method comprises the following steps: pulverizing levofloxacin tablets and the radix cynanchi wilfordii food retention removing granules, mixing, adding water, stirring and dissolving to obtain a mixed solution;
step two: and (4) using the auxiliary pipe to flow the mixed liquid in the step one into the prostate of the patient, and the patient lies on the stomach to wait for 30min.
In a preferred embodiment, in the first step, the mass of the levofloxacin tablet is 0.3g, the mass of the cynanchum wilfordii stasis removing granule is 6g, and the mass of the water is 12g.
In a preferred embodiment, the administration of the drug to the prostate of the patient in step two requires that the patient be on his or her stomach.
The levofloxacin tablets and the radix cynanchi wilfordii dyspepsia granules are mixed and dissolved and then flow into the prostate of a patient, the mixed liquid medicine enters the prostate by adopting a medicine feeding way on the front, and the effect on impotence and prostatitis is better by mixing the levofloxacin tablets and the radix cynanchi wilfordii dyspepsia granules.
It should be noted that, in this document, relational terms such as first and second, and the like are used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (3)
1. A method of treating impotence and prostatitis characterized by: the method comprises the following steps:
the method comprises the following steps: pulverizing levofloxacin tablets and the radix cynanchi wilfordii food retention removing granules, mixing, adding water, stirring and dissolving to obtain a mixed solution;
step two: and (4) using an auxiliary pipe to flow the mixed liquid in the step one into the prostate of the patient, and waiting for 20-40min when the patient lies on the stomach.
2. A method of treating impotence and prostatitis as claimed in claim 1 wherein: in the first step, the mass of the levofloxacin tablets is 0.2-0.4g, the mass of the Daoshan Xiaojie granules is 4-8g, and the mass of water is 10-15g.
3. A method of treating impotence and prostatitis as claimed in claim 1 wherein: and in the second step, the patient is required to face forward to take the medicine when the medicine is taken for the prostate of the patient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211424784.1A CN115844934A (en) | 2022-11-14 | 2022-11-14 | A method for treating sexual impotence and prostatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211424784.1A CN115844934A (en) | 2022-11-14 | 2022-11-14 | A method for treating sexual impotence and prostatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115844934A true CN115844934A (en) | 2023-03-28 |
Family
ID=85663433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211424784.1A Pending CN115844934A (en) | 2022-11-14 | 2022-11-14 | A method for treating sexual impotence and prostatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115844934A (en) |
-
2022
- 2022-11-14 CN CN202211424784.1A patent/CN115844934A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106692307B (en) | Hydrogel for treating female cervical erosion and preparation method thereof | |
| CN103565954A (en) | Application of Wantong muscle and bone patch in medicament for treating scapulohumeral periarthritis | |
| CN103656025B (en) | A kind of medical liquor for treating injury | |
| CN115844934A (en) | A method for treating sexual impotence and prostatitis | |
| CN107551014B (en) | Traditional Chinese medicine cataplasm for diminishing inflammation and relieving pain and preparation method thereof | |
| CN102078472A (en) | Medicament for treating verruca wart | |
| CN103301365B (en) | Cataplasm for treating cervical spondylosis and preparation method thereof | |
| CN103272195B (en) | Traditional Chinese medicine paste for treating pain | |
| CN110755515A (en) | Navel treatment rod for treating mammary gland exhaustion and preparation method thereof | |
| CN110123925A (en) | It is a kind of to treat hydrocephalic nasal nanometer emulsion in-situ gel and preparation method thereof | |
| CN103520638B (en) | A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof | |
| CN110787237B (en) | Traditional Chinese medicine composition for effectively treating gastrocnemius spasm and preparation method and application thereof | |
| CN102698126B (en) | Traditional Chinese medicine compound having effect of treating prostatitis and preparation method thereof | |
| CN105999116B (en) | Traditional Chinese medicine enema prescription for treating chronic pelvic pain | |
| CN108853297A (en) | A kind of external application Chinese medicine for treating traumatic injury | |
| CN105726967A (en) | Chinese herbal preparation for treating post-anesthesia nerve injury | |
| CN106822524B (en) | Compound medicine for treating infertility and preparation method and application thereof | |
| CN105030983A (en) | External use traditional Chinese medicine for treating eczema | |
| CN104606578A (en) | Traditional Chinese medicine composition for treating superficial thrombophebitis caused by medicine | |
| CN104524133A (en) | Traditional Chinese medicinal composition for kidney tonifying, exterior strengthening and beauty treating | |
| CN117883541A (en) | Traditional Chinese medicine composition for treating cold coagulation stasis type dysmenorrhea | |
| CN104784420A (en) | Traditional Chinese medicine composition for preventing hematodialysis chronic persistent hypotension | |
| CN101979046A (en) | Medicament for treating tonsillitis | |
| CN104689229A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN118304347A (en) | Fengtong plaster for department of traumatology and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20230328 |
|
| WD01 | Invention patent application deemed withdrawn after publication |